DYADIC INTERNATIONAL INC — Investor Relations & Filings

Dyadic International, Inc. is a global biotechnology company focused on the development and application of its proprietary microbial platforms for producing recombinant proteins and enzymes. The company's core technologies, the C1 and Dapibus™ expression systems, are derived from the Thermothelomyces heterothallica fungus and are engineered to enable faster, more scalable, and cost-effective biomanufacturing. Dyadic licenses its platforms to partners for use in various markets, including life sciences (therapeutics, diagnostics, research reagents), food and nutrition (animal-free proteins), and bio-industrial applications (biofuels, textiles, specialty chemicals). The technology aims to overcome the production limitations of traditional methods, facilitating the development of more efficient and sustainable products.